News ArticleShriram Finance Schedules Group Meeting with Select Investors at Avendus Spark Investor Conference on November 16, 2026
Senior management to attend Mumbai meeting discussing investor presentation and public disclosures
Shriram Finance Limited schedules a group meeting with select investors at the Avendus Spark Investor Conference in Mumbai on November 16, 2026. Senior management will discuss company updates based on investor presentations and publicly available disclosures.
Shriram Finance Limited
Investor Presentation
Shriram Finance Limited announced a group meeting with select investors, scheduled for November 16, 2026, in Mumbai, to be attended by senior management.
The meeting will take place at the Avendus Spark Investor Conference and involves discussions based on the company’s investor presentation and information available in the public domain.
This event aims to facilitate communication between Shriram Finance’s management and select investors, brokers, and analysts.
The announcement was made on November 5, 2026, and the information has been posted on the company’s official website.
Highlights
- Group meeting with select investors scheduled for November 16, 2026, in Mumbai.
- Meeting to be attended by senior management and company personnel.
- Discussion will revolve around investor presentations and publicly disclosed information.
- Event is part of the Avendus Spark Investor Conference.
- Information also hosted on Shriram Finance’s website.
Key Data Snapshot
What happened
- Shriram Finance scheduled a group meeting with select investors as part of the Avendus Spark Investor Conference.
- The meeting is set for November 16, 2026, in Mumbai.
- Senior management and company officials will attend the meeting.
Key details
- Discussions at the meeting will be based on the company’s investor presentation and publicly available disclosures.
- The purpose is to engage with funds, analysts, institutional investors, and brokers in a group format.
- The information is also available on Shriram Finance’s corporate website.
Regulatory and governance context
- Disclosure made pursuant to Regulation 30 of the SEBI Listing Regulations 2015.
- Announcement ensures compliance with listing obligations related to investor communication.
Highlights
- Group meeting with select investors scheduled for November 16, 2026, in Mumbai.
- Meeting to be attended by senior management and company personnel.
- Discussion will revolve around investor presentations and publicly disclosed information.
- Event is part of the Avendus Spark Investor Conference.
- Information also hosted on Shriram Finance’s website.
Disclosures
- Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Source Information
More News on Investor Presentation
View allLatest corporate announcements and market updates in Investor Presentation.
Rubicon Research Limited Reports Nearly 40% Revenue Growth and 68% Profit Increase in Q2 FY26-27
Rubicon Research Limited posted significant financial growth for the quarter ended September 30, 2026, with revenue increasing by 39.9% year-on-year to ₹5,764 million and profit after tax rising 67.9% to ₹904 million. This performance includes the consolidation impact of its recent Arinna acquisition and reflects strong operational cash flows and product approvals.
Read Full Story
Inventurus Knowledge Solutions Reports Q2 FY27 Investor Presentation Highlighting AI-Driven Growth and Platform Innovation
Inventurus Knowledge Solutions Limited disclosed its investor presentation for the quarter and half-year ended September 30, 2026, emphasizing advancements in its AI-powered healthcare enablement platform, strategic execution plans, and ongoing partnerships to drive growth and optimize margins.
Read Full Story
Sai Life Sciences Reports 23% Revenue Growth in Q2 FY27 with ₹659 Crore Revenue Amid Strategic Expansion
Sai Life Sciences Limited announced a 23% year-over-year revenue growth to ₹659 crore for the second quarter of fiscal year 2027, supported by healthy performance in both its Contract Research (CRO) and Contract Development and Manufacturing Organization (CDMO) segments. The company reported an EBITDA margin of 28% and continued its capital expenditure with ₹621 crore invested in the first half of FY27 to expand capacity and capabilities.
Read Full Story
